JZWGMGWQHXSVTH-OAQYLSRUSA-N
C27H29F4N5O5 — CID 118417402
Data last refreshed: (MolForge compound catalog, from PubChem)
About JZWGMGWQHXSVTH-OAQYLSRUSA-N
JZWGMGWQHXSVTH-OAQYLSRUSA-N (PubChem CID 118417402) has the molecular formula C27H29F4N5O5 and a molecular weight of 579.55 g/mol. Its IUPAC name is 2-fluoro-N-[(2R)-1-[1-(6-methoxy-3-pyridinyl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-3-methyl-1-oxobutan-2-yl]-5-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | JZWGMGWQHXSVTH-OAQYLSRUSA-N |
|---|---|
| PubChem CID | 118417402 |
| Molecular Formula | C27H29F4N5O5 |
| Molecular Weight | 579.55 g/mol |
| Exact Mass | 579.21 |
| IUPAC Name | 2-fluoro-N-[(2R)-1-[1-(6-methoxy-3-pyridinyl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]-3-methyl-1-oxobutan-2-yl]-5-(trifluoromethyl)benzamide |
| SMILES | COc1ccc(N2C(=O)N(C)C(=O)C23CCN(C(=O)[C@H](NC(=O)c2cc(C(F)(F)F)ccc2F)C(C)C)CC3)cn1 |
| InChI | InChI=1S/C27H29F4N5O5/c1-15(2)21(33-22(37)18-13-16(27(29,30)31)5-7-19(18)28)23(38)35-11-9-26(10-12-35)24(39)34(3)25(40)36(26)17-6-8-20(41-4)32-14-17/h5-8,13-15,21H,9-12H2,1-4H3,(H,33,37)/t21-/m1/s1 |
| InChIKey | JZWGMGWQHXSVTH-OAQYLSRUSA-N |
| XLogP | 3.46 |
| TPSA | 112.15 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 579.55 |
| LogP ≤ 5 | 3.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118417402 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.